Which children with fever and neutropenia can be safely treated as outpatients?
Annotation
Craig A. Mullen,
Craig A. Mullen
Department of Pediatrics, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorCraig A. Mullen,
Craig A. Mullen
Department of Pediatrics, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this author Craig A. Mullen, M.D., Ph.D., Department of Paediatrics, University of Texas M. D. Anderson Cancer Center, Box 88, Room B7·4518, 1515 Holcombe Boulevard, Houston, TX 77030, USA. E-mail: [email protected]
References
- Aquino, V.M., Tkaczewski, I., Buchanan, G.R. (1997) Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clinical Infectious Diseases, 25, 74–78.
- Bodey, G.P., Buckley, M., Sathe, Y.S., Freireich, E.J. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine, 64, 328–340.
- Buchanan, G.R. (1993) Approach to treatment of the febrile cancer patient with low-risk neutropenia. Hematology–Oncology Clinics of North America, 7, 919–935.
- Freifeld, A., Marchigiani, D., Walsh, T., Chanock, S., Lewis, L., Hiemenz, J., Hiemenz, S., Hicks, J.E., Gill, V., Steinberg, S.M., Pizzo, P.A. (1999) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. New England Journal of Medicine, 341, 305–311.
- Hann, I., Viscoli, C., Paesmans, M., Gaya, H., Glauser, M. (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC trials. British Journal of Haematology, 99, 580–588.
- Hughes, W.T., Armstrong, D., Bodey, G.P., Brown, A.E., Edwards, J.E., Feld, R., Pizzo, P., Rolston, K.V., Shenep, J.L., Young, L.S. (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clinical Infectious Diseases, 25, 551–573.
- Jones, G.R., Konsler, G.K., Dunaway, R.P., Pusek, S.N. (1996) Infection risk factors in febrile, neutropenic children and adolescents. Pediatric Hematology and Oncology, 13, 217–229.
- Kaplinsky, C., Drucker, M., Goshen, J., Tamary, H., Cohen, I.J., Zaizov, R. (1994) Ambulatory treatment with ceftriaxone in febrile neutropenic children. Israel Journal of Medical Sciences, 30, 649–651.
- Kern, W.V., De Cometta, A.B.R., Langenaeken, J., Paesmans, M., Gaya, H. (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. New England Journal of Medicine, 341, 312–318.
- Lau, R.C., Doyle, J.J., Freedman, M.H., King, S.M., Richardson, S.E. (1994) Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatric Hematology and Oncology, 11, 417–421.
-
Lau, R.C.W.,
Matsui, D.,
Greenberg, M.,
Koren, G. (1998) Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia.
Medical and Pediatric Oncology, 30, 85–90.DOI: 10.1002/(sici)1096-911x(199802)30:2<85::aid-mpo3>3.3.co;2-s
10.1002/(SICI)1096-911X(199802)30:2<85::AID-MPO3>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
-
Lucas, K.G.,
Brown, A.E.,
Armstrong, D.,
Chapman, D.,
Heller, G. (1996) The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteraemia and complications of sepsis.
Cancer, 77, 791–798.DOI: 10.1002/(sici)1097-0142(19960215)77:4<791::aid-cncr27>3.3.co;2-b
10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V PubMed Web of Science® Google Scholar
- Malik, I.A. (1997) Out-patient management of febrile neutropenia in indigent paediatric patients. Annals of the Academy of Medicine, Singapore, 26, 742–746.
-
Mullen, C.A.,
Petropoulos, D.,
Roberts, W.M.,
Rytting, M.,
Zipf, T.,
Chan, K.W.,
Culbert, S.C.,
Danielson, M.,
Jeha, S.,
Kuttesch, J.F.,
Rolston, K.V. (1999a) Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Cancer, 86, 126–134.DOI: 10.1002/(sici)1097-0142(19990701)86:1<126::aid-cncr18>3.3.co;2-t
10.1002/(SICI)1097-0142(19990701)86:1<126::AID-CNCR18>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar
- Mullen, C.A., Petropoulos, D., Roberts, W.M., Rytting, M., Zipf, T., Chan, K.W., Culbert, S.J., Danielson, M., Jeha, S.S., Kuttesch, J.F., Rolston, K.V. (1999b) Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer. Journal of Pediatric Hematology/Oncology, 21, 212–218.
- Mullen, C.A., Nair, J., Sandesh, S., Chan, K.W. (2000) Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplantation, 25, 59–65.
- Mustafa, M.M., Aquino, V.M., Pappo, A., Tkaczewski, I., Buchanan, G.R. (1996) A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteraemia. Journal of Pediatrics, 128, 847–849.
- Patrick, C.C. & Shenep, J.L. (1999) Outpatient management of the febrile neutropenic child with cancer. Advances in Pediatric Infectious Diseases, 14, 29–47.
- Peterson, D.E. (1999) Research advances in oral mucositis. Current Opinion in Oncology, 11, 261–266.
-
Petrilli, A.S.,
Dantas, L.S.,
Campos, M.C.,
Tanaka, C.,
Ginani, V.C.,
Seber, A. (2000) Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Medical and Pediatric Oncology, 34, 87–91.DOI: 10.1002/(sici)1096-911x(200002)34:2<87::aid-mpo2>3.0.co;2-f
10.1002/(sici)1096-911x(200002)34:2<87::aid-mpo2>3.0.co;2-f CAS PubMed Web of Science® Google Scholar
- Pizzo, P.A. (1993) Management of fever in patients with cancer and treatment-induced neutropenias. New England Journal of Medicine, 328, 1323–1332.
- Pizzo, P.A., Robichaud, K.J., Gill, F.A., Witebsky, F.G., Levine, A.S., Deisseroth, A.B., Glaubiger, D.L., Maclowry, J.D., Magrath, I.T., Poplack, D.G., Simon, R.M. (1979) Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. American Journal of Medicine, 67, 194–200.
- Pizzo, P.A., Robichaud, K.J., Gill, F.A., Witebsky, F.G. (1982) Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. American Journal of Medicine, 72, 101–111.
- Preis, S., Göbel, U., Jürgens, H. (1997) Outpatient treatment with ceftriaxone alone or in combination with teicoplanin in febrile neutropenic children and adolescents with cancer. Journal of Pediatrics, 130, 500–501.
- Rackoff, W.R., Gonin, R., Robinson, C., Kreissman, S.G., Breitfeld, P.P. (1996) Predicting the risk of bacteraemia in children with fever and neutropenia. Journal of Clinical Oncology, 14, 919–924.
- Rolston, K.V., Rubenstein, E.B., Freifeld, A. (1996) Early empiric antibiotic therapy for febrile neutropenia patients at low risk. Infectious Disease Clinics of North America, 10, 223–237.
-
Ruescher, T.J.,
Sodeifi, A.,
Scrivani, S.J.,
Kaban, L.B.,
Sonis, S.T. (1998) The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies.
Cancer, 82, 2275–2281.DOI: 10.1002/(sici)1097-0142(19980601)82:11<2275::aid-cncr25>3.3.co;2-8
10.1002/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- Sahu, S., Bapna, A., Pai, S.K., Nair, C.N., Kurkure, P.A. (1997) Outpatient antimicrobial protocol for febrile neutrpenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents. Pediatric Hematology and Oncology, 14, 205–211.
-
Shemesh, E.,
Yaniv, I.,
Drucker, M.,
Hadad, S.,
Goshen, Y.,
Stein, J.,
Ash, S.,
Fisher, S.,
Zaizov, R. (1998) Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients.
Medical and Pediatric Oncology, 30, 95–100.DOI: 10.1002/(sici)1096-911x(199802)30:2<95::aid-mpo5>3.3.co;2-l
10.1002/(SICI)1096-911X(199802)30:2<95::AID-MPO5>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
- Sundararajan, V., Rubenstein, E.B., Rolston, K.V.I., Elting, L.S. (1997) Controversies in new antibiotic therapy for ambulatory patients. Supportive Care in Cancer, 5, 358–364.DOI: 10.1007/s005200050092
- Talcott, J.A., Finberg, R., Mayer, R.J., Goldman, L. (1988) The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Archives of Internal Medicine, 148, 2561–2568.
-
Tebbi, C.K.,
Cummings, M.,
Zevon, M.A.,
Smith, L.,
Richards, M.,
Mallon, J. (1986) Compliance of pediatric and adolescent cancer patients.
Cancer, 58, 1179–1184.
10.1002/1097-0142(19860901)58:5<1179::AID-CNCR2820580534>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- Wingard, J.R. (1990) Infectious and noninfectious systemic consequences. Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. NCI Monographs, 9, 21–26.
-
Wingard, J.R.,
Santos, G.W.,
Saral, R. (1987) Differences between first and subsequent fevers during prolonged neutropenia.
Cancer, 59, 844–849.
10.1002/1097-0142(19870215)59:4<844::AID-CNCR2820590431>3.0.CO;2-U CAS PubMed Web of Science® Google Scholar
Citing Literature
